Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

COMMUNITY DSE. 1 > PTB > Flashcards

PTB Flashcards

1
Q

Highly infectious chronic dse. Caused by tubercle bacilli

A

Pulmonary TB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

CAUSATIVE AGENTS

A
  1. Mycobacterium tuberculae
  2. M. Africanum
  3. M. Bovis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Classification

A

Bacterial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

TB among children

A

Primary complex (not contagious)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

2 types of TB

A
  1. Pulmonary TB- micro-bacterium within lungs
  2. Extrapulmonary TB- adjacent organs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mode of transmission
D, A, D, I

A

DROPLET
AIRBORNE
DIRECT INVASION (rare)
INGESTION OF UNPASTEURIZED MILK OR DAIRY PRODUCTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Extreme temp to destroy microorganisms in unpasteurized milk

A

63 deg celsius (30mins)/71.6-71.7 deg F (5-15secs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Incubation period

A

2-8 wks (12 wks max)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Period of communicability

A
  • while bacillus is in the sputum
  • good compliance to regimen (not contagious 2-4 wks. After)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Terminologies
C, H, H

A
  1. Close contact
  2. High risk group
  3. High risk clinical group
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Close contact

A

Enclosed space for 3 mos.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

High risk group

A

Closed environment (prison cell, skin-to-skin contact)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

High risk clinical group

A

AIDS/HIV/DM/RF (immunocompromised pt.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

6 Cardinal sign of PTB
C, NS, WL, A, H, LGF (CNS, WLAH, LGF)

A

Cough productive
Night sweats
Weight loss
Anorexia
Hemoptysis
Low grade fever in the afternoon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Dx test

A
  1. DSSM (Direct sputum smear microscopy)
  2. X-rays
  3. TST (Tuberculin Skin Test- primary complex)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

DSSM
Conventional strategy (SPOT)

A

Instruct the patient to return the next day, early in the morning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

DSSM
SPOT-SPOT

A

3 SPECIMENS
1st- right away/after chief complaint
2nd- after 1 hr
3rd- the next day, early in the morning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Sputum analysis

A

If 2 sputum are (+) = PTB
If 1 (-) and 1 (+) = Chest x-ray

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Classification based on history of previously TB treatment
N, R, T, T, O, P (Nursing Reaching To TOP)

A

New pt.
Relapse pt.
Treatment after failure
Treatment after loss to follow up pt.
Other previously treated pt.
Pt. With unknown previous TB treatment history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

New pt

A

Not yet diagnosed/ with TB before and taking anti-tubercular drug for 2 mos.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Relapse pt.

A

After receiving treatment for her TB, pt. Was diagnosed again with the illness

22
Q

Treatment after failure pt.

A

The TB treatment was unsuccessful

23
Q

Treatment after loss to follow-up pt.

A

Return after default/loss of contract or follow up for 2 mos.

24
Q

Other previously treated pt.

A

No known treatment/undocumented TB treatment

25
Q

Pt. With unknown previous TB treatment history

A

Does not fit in any category under classification of previous TB treatment

26
Q

DOTS

A

Directly Observed Treatment Short Course
- appointed person to monitor the daily intake (assigned health worker)

27
Q

Intensive phase

A

2 mons.

28
Q

Maintenance phase

A

4 mos.

29
Q

Recommended category of treatment regimen
4C’s?

A

C1, 2, 3, 4

30
Q

C1

A
  • new PTB, (+) smear, extensive parenchymal lesions (lungs), seriously ill, x-ray
    IP: 2 mos. HRZE (RIPE)
    MP: 4 mos. HR (RI)
31
Q

C2

A

Relapse, tx failure, return after default, and others
IP: 2 mos. HRZES (RIPES)
MP: 5 mos. HRE (RIE)

32
Q

C3

A

New PTB, with minimal lesions, not seriously ill
IP: 2 mos. HRZ (RIP)
MP: 4 mos. HR (RI)

33
Q

C4

A

Chronic PTB, (+) TB, (+) SPUTUM SMEAR AFTER SUPERVISED TX.
No meds

34
Q

Scone line drugs: Injectables
Aminoglycosides

A

Kanamycin
Amikacin
Capreomycin

35
Q

Second line drugs: Oral
Fluoroquinolone

A

Levofloxacin
Ciprofloxacin
Moxifloxacin

36
Q

JAUNDICE

A

RIPE

37
Q

Visual impairment

A

Ethambutol

38
Q

Tinnitus and hearing impairment

A

Streptomycin

39
Q

Oliguria and albuminiria

A

Strep and rifampicin

40
Q

Psychosis and convulsion

A

Isoniazid

41
Q

thrombocytopenia & anemia

A

Rifampicin

42
Q

DR- TB

A

DRUG RESISTANCE- ISONIAZID

43
Q

MDR- TB

A

MULTIPLE DRUG RESISTANCE- ISO & RIFAM

44
Q

XDR-TB

A

EXTENSIVELY DRUG RESISTANCE- ISO, RIFAM, FLUORO

45
Q

XXDR-TB

A

EXTREMELY DRUG RESISTACE- ISO, RIFAM, & FLUORO

46
Q

TDR- TB

A

TOTAL DRUG RESISTANCE- ISO, RIFAM, FLUORO

47
Q

RIFAM (SE)

A

RED ORAGE URINE, SWEAT, TEARS, SEMEN

48
Q

ISO (SE)

A

PERIPHERAL NEURITIS (PRICKILING OR TINGLING SENSATION)
VIT B6 FOR SE

49
Q

PYRAZINAMIDE (SE)

A

HYPERURICEMIA (INCREASED URIC ACID OR GOUT)
NEPHROTOXICITY/HEPATOTOXICITY (ALT & AST)

50
Q

ETHAMBUTOL (SE)

A

OPTIC NEURITIS/ BLURRING OF VISION

51
Q

STREP (SE)

A

8TH CRANIAL NERVE
VERTIGO & TINNITUS

52
Q

MANTOUX TEST (PURIFIED PROTEIN DERIVATIVE)

A

ROUTE OF ADMINISTRATION: ID

WHEAL FORMATION
(+) 10mm - exposure to normal people
(+) 5mm- exposure to immunocompromised people (HIV/AIDS)

COMMUNITY DSE. 1 (19 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions